Navigation Links
Pitt receives $2.8 million to train HIV/AIDS researchers in Mozambique, Brazil and India
Date:4/17/2009

PITTSBURGH, April 17 The University of Pittsburgh has received a five-year, $2.8 million grant from the National Institutes of Health's Fogarty International Center to train researchers in regions of the world most hard-hit by the HIV/AIDS epidemic. The grant, part of the center's AIDS International Training and Research Program (AITRP), will allow Pitt to develop a training site in Mozambique, where there are an estimated 750 new HIV infections every day, and to expand programs underway in Brazil and India.

"The HIV/AIDS epidemic remains uncontrolled in many regions in the world," said principal investigator Lee Harrison, M.D., professor of medicine and epidemiology, University of Pittsburgh. "With an ever-growing number of patients in treatment programs, there is an urgent need for well-trained scientists to monitor patients and find out why people develop resistance to anti-HIV drugs." He said the Fogarty grant will give international researchers the tools and skills needed to do this vital work.

"America has become the leader in advancing prevention and treatment of HIV/AIDS in developing countries," said Roger I. Glass, M.D., Ph.D., director of the Fogarty International Center. "Training local researchers benefits their own countries and helps U.S. scientists develop new understanding and methods for combating disease."

The Pitt training program in Mozambique is based on a partnership forged in 2006 with Catholic University Mozambique, the site of one of only two medical schools in the southeastern African country. With 1.8 million people living with HIV and one physician for every 33,000 residents, Mozambique has very limited capabilities for research and few trained investigators, Dr. Harrison said. The growing epidemic disproportionately impacts women, many of them of childbearing age. In the region of Beira, where Catholic University is based, 34 percent of pregnant women are HIV-infected.

In Mozambique, the Pitt team will focus on training researchers in epidemiological methods to better understand the failure of antiretroviral treatment and answer basic questions about HIV prevalence. In Brazil, ranked second in number of reported AIDS cases in the Americas, training will focus on treatment and vaccine trials, tuberculosis research related to AIDS and the effectiveness of antiretroviral therapy in public clinics. In India, where there are 2.5 million HIV-infected people, training will center on laboratory studies on the molecular mechanisms of HIV and the development of anti-HIV vaccines using Indian strains.

The University of Pittsburgh received one of seven AITRP grants recently awarded. The AITRP has trained nearly 2,000 researchers overseas, most of whom remain in their countries to continue HIV/AIDS research, train young scientists and provide leadership to their governments on health issues. Co-directing the program with Dr. Harrison is Phalguni Gupta, Ph.D., professor in the Department of Infectious Diseases and Microbiology at the University of Pittsburgh Graduate School of Public Health.


'/>"/>

Contact: Clare Collins
CollCX@upmc.edu
412-647-3555
University of Pittsburgh Schools of the Health Sciences
Source:Eurekalert

Related medicine news :

1. Wellesse Receives Corporate Sponsor of the Year Award From the Arthritis Foundations Pacific Northwest Chapter
2. Kaiser Permanente Receives Top Marks in 2009 J.D. Power and Associates Study
3. Zultys Inc. Receives 2009 NGN Leadership Award from NGN Magazine
4. Sage Intergy EHR Receives 08 CCHIT Certification
5. Sirion Therapeutics Announces Positive Results From Interim Analysis of Phase II Trial and Receives FDA Fast Track Designation for Fenretinide
6. ExpressMD(TM) Solutions Remote Patient Health Monitoring Device Receives 510(K) Market Clearance Approval From FDA
7. Alseres Pharmaceuticals, Inc. Receives Notice of De-Listing of Its Securities for Failure to Regain Compliance with Continued Listing Requirements
8. Milton resident receives the Helen B. Spaulding Community Conscience Award
9. IDM Pharma Receives Nasdaq Shareholder Equity Notification
10. DaVita Dietitian Receives 2009 National Kidney Foundation Award for Outstanding Contributions to Renal Health
11. Xoft Receives Health Canada Regulatory Approval for the Axxent(R) Electronic Brachytherapy System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... NY & Salt Lake City, UT (PRWEB) , ... February 05, ... ... Founder of Activz Whole-Food Nutrition , announced that the much-anticipated feature with author ... the New Really Cool Humans Amateur TV Network. , Each week, on his weekly ...
(Date:2/5/2016)... ... February 05, 2016 , ... The event is being held ... Event Center in Minneapolis, Minn. Triumph Over Parkinson’s will fund nearly $100,000 for research ... Schneiderman’s Furniture, lives with Parkinson’s disease and is the architect of this informative event ...
(Date:2/5/2016)... ... February 05, 2016 , ... ... addition of micro-needling services in their Napa Valley office. The technique utilizes the ... Surgery Associates, Dr. Canales and Dr. Furnas, are part of only a select ...
(Date:2/5/2016)... ... February 05, 2016 , ... ... H. Van Allen have signed a joint enrollment and degree completion agreement. ... toward associate and baccalaureate degrees at FHU|Dickson. , The agreement allows students ...
(Date:2/5/2016)... ... February 05, 2016 , ... ... exclusively to funding innovative lymphoma research and serving the lymphoma community through a ... to once again host, Swirl, A Wine Tasting Event at the La Gorce ...
Breaking Medicine News(10 mins):
(Date:2/4/2016)... , Feb. 4, 2016 Summary Breast ... cancer and the most common cancer in women worldwide, ... disease exceedingly prevalent. The number of women diagnosed with ... but the number of deaths has declined due to ... treatment has been revolutionized in the past four decades, ...
(Date:2/4/2016)... Feb. 4, 2016 Mettler-Toledo International Inc. (NYSE: ... 2015.  Provided below are the highlights: , ... compared with the prior year.  Reported sales decreased 3% ... quarter. , Net earnings per diluted share as ... prior- year period.  Adjusted EPS was $4.65, an increase ...
(Date:2/4/2016)... 2016  Blueprint Medicines Corporation (NASDAQ: BPMC ... selective investigational kinase medicines for patients with genomically ... board of directors of Lonnel Coats , ... of industry-related experience. Jeffrey Albers ... strong strategic experience developing and commercializing numerous oncology ...
Breaking Medicine Technology: